Rheumatoid lung disease
Human disease

Rheumatoid lung disease is a disease of the lung associated with RA, rheumatoid arthritis. Rheumatoid lung disease is characterized by pleural effusion, pulmonary fibrosis, lung nodules and pulmonary hypertension. Common symptoms associated with the disease include shortness of breath, cough, chest pain and fever. It is estimated that about one quarter of people with rheumatoid arthritis develop this disease, which are more likely to develop among elderly men with a history of smoking.
Rheumatoid lung is separate from but often associated with Interstitial lung disease(ILD).
Signs and symptoms
Most common:
Chest Pain
Cough
Fever
Shortness of breath
Joint pain, stiffness, swelling
Skin nodules
People may not present with all these symptoms or none at all.
From most to least common:
Pleural involvement (pleurisy, effusions)
Pulmonary parenchymal nodules, more common in men than in women
Rheumatoid-associated interstitial lung disease
Bronchiolitis obliterans organizing pneumonia
Obliterative bronchiolitis (obstructive lung disease/bronchiectasis)
Rheumatoid-associated pulmonary hypertension
Pulmonary vasculitis/arteritis
Shrinking lung syndrome
Miscellaneous: MTX, cricoarytenoid arthritis, infection, cancer
Causes
The exact cause of rheumatoid lung disease is unknown. However, associated factors could be due largely to smoking. Sometimes, the medicines used to treat rheumatoid arthritis, especially methotrexate, may result in lung disease.
Prevention:
Stop smoking: Chemicals found in cigarettes can irritate already delicate lung tissue, leading to further complications.
Begin with the source’s own compact description: “Rheumatoid lung disease” is human disease. The dossier treats that line as a proposition to test through Rheumatoid, lung and disease, not as a finished interpretation.
Why this record matters
The phrase “human disease” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jul 15, 2025. The linked authority identifier is Q7320486. None of the 0 selected statements returned an explicit reference.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Rheumatoid lung disease”, its source revision and the description used here.
- Expand the search: follow Rheumatoid lung disease primary sources, Rheumatoid lung disease archive and Rheumatoid research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Rheumatoid lung disease”?
- What terminology or title could unlock a more precise catalogue search?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Rheumatoid lung disease” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.